查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1837245

血栓切除器械市场（按器械、手术、技术、分销管道和最终用户划分）—2025-2032年全球预测

Thrombectomy Devices Market by Device, Procedure, Technology, Distribution Channel, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，血栓切除装置市场将成长至 33 亿美元，复合年增长率为 7.64%。

关键市场统计数据
基准年2024年 18.3亿美元
预计年份：2025年 19.7亿美元
预测年份 2032 33亿美元
复合年增长率 (%) 7.64%

在器械工程、影像融合技术的进步以及临床证据的不断累积的推动下，血栓切除器械已从小众介入治疗转变为多种急性血管疾病治疗路径中不可或缺的工具。本文概述了目前血栓切除术的现状：临床医生、医院系统和专科中心越来越依赖快速的机械方法和多学科协作来清除脑、静脉和肺循环中的阻塞性血栓。随着器械技术的不断发展，不同手术类型和技术模式之间的界限也日益模糊，从而促进了神经介入医师、血管外科医师和介入放射科医师之间的跨学科合作。

因此，医疗器材的采购和使用决策不再仅基于成本或品牌知名度。相反，临床结果数据、在混合手术环境中的易用性、供应商提供的培训支援以及供应的连续性才是关键决定因素。同时，监管机构也完善了医疗器材核准和上市后监测流程，更重视实际应用性能指标。综上所述，这些变化凸显了相关人员需要将临床需求与营运弹性相结合，以适应不同医疗保健系统对快速再灌注治疗和标准化诊疗路径日益增长的需求。

技术创新在设备设计、影像整合和诊疗路径优化方面的融合如何重塑医疗机构的临床应用和投资格局

血栓切除器械领域正经历变革性的转变，这主要得益于技术创新、手术流程标准化以及医疗系统对速度和疗效的重视。小型化和材料科学的进步提高了器械在复杂血管解剖结构中的可追踪性和输送性，而新的设计则拓展了抽吸技术和支架取栓平台的治疗范围。同时，影像技术和术中导航系统的日益成熟，使得器械定位更加精准，手术时间也得以缩短。

监管和报销环境也在不断变化，越来越多的支付方认识到及时进行机械再灌注治疗对中风和肺栓塞病例的后续成本效益。这些变化奖励医疗机构投资于培训、混合手术室设施和流程优化，以最大限度地提高首次治疗的成功率。此外，医疗器材製造商和临床网路之间的合作日益密切，旨在透过结构化的培训项目，产生可靠的真实世界证据并加速技术应用。因此，目前的技术应用模式反映了技术创新应用曲线与库存管理、人员能力以及与急诊治疗路径的契合度等实际因素之间的平衡。

评估新实施的关税对血栓切除器械相关人员的供应链、筹资策略和总成本的多方面影响

美国将于2025年实施新的关税，这为本已错综复杂的血栓切除器械全球供应链增添了新的复杂性。虽然这些关税旨在保护国内製造业和战略产业，但也改变了依赖跨境生产专用零件和原材料的公司的成本结构。在关键市场拥有垂直整合供应链的製造商能够更好地吸收或缓解关税带来的成本压力，而依赖受影响地区单一供应商的公司则面临采购稳定性的下降。

为此，许多相关人员加快了主动风险管理措施的实施，包括供应商多元化、将关键生产环节迁回国内以及重新谈判长期合约以确保有利条款。经销商和医院采购团队都加强了库存计划，以防止在过渡性关税实施期间出现短期缺货。重要的是，筹资策略的重点从单纯的单位成本转向评估总体拥有成本，并考虑了前置作业时间可预测性、保固和服务以及培训支援等因素。展望未来，关税的累积影响使得策略性供应链韧性成为医疗器材製造商和医疗保健系统持续获得关键血栓清除技术的核心竞争优势。

全面的細項分析揭示了设备类别、手术亚型、技术方法、分销策略和医疗环境如何驱动临床和商业优先事项。

细緻的市场细分视角揭示了器械选择、手术适应症、底层技术、分销管道以及终端用户偏好如何塑造市场动态和临床工作流程。依器械类型划分，市场可分为抽吸导管和血栓摘取支架，二者在输送性、血栓累及程度及预期首过疗效方面各有不同。临床医师会根据病变形态、血管通路复杂度和操作者熟练程度选择合适的器械。依手术类型划分，血栓切除术的应用涵盖深层静脉栓塞症、缺血性中风和肺动脉栓塞。深层静脉栓塞症形成可分为远端深部静脉血栓形成和髂股深部静脉血栓形成，缺血性中风可分为闭塞前和闭塞后，肺动脉栓塞可分为高容量肺栓塞和低容量肺栓塞。这些手术类型决定了具体的器械设计重点、辅助技术以及所需的临床医生技能。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 双机制抽吸和支架取栓装置在综合中风治疗的应用日益广泛
  • 加强人工智慧驱动的影像和即时分析的整合，以优化血栓切除术的效果
  • 对用于远端血管再通的可导航导管设计的需求日益增长
  • 扩展可携式和移动式介入治疗设备，以便在现场实现快速中风介入治疗。
  • 开发可生物降解和药物释放型洗脱血栓切除装置以降低再闭塞率
  • 引入机器人导管引导系统，以提高复杂颅内手术的精确度
  • 医疗器材製造商与远距中风医疗网路建立策略伙伴关係，以支援远距手术

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 血栓切除器械市场：依器械分类

  • 吸管
  • 支架取栓器

9. 依手术类型分類的血栓切除器械市场

  • 深层静脉栓塞症
    • 远端
    • 髂骨和股骨
  • 缺血性中风
    • 前循环
    • 后循环
  • 肺动脉栓塞
    • 大规模
    • 半大型

第十章 血栓切除器械市场：依技术分类

  • 雷射辅助
  • 机器
  • 药理机制

第十一章 血栓切除器械市场（依通路划分）

  • 直销
  • 线上平台

第十二章 依最终用户分類的血栓切除器械市场

  • 门诊手术中心
  • 医院
  • 专科诊所

第十三章 血栓切除器械市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 血栓切除器械市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国血栓切除器材市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Penumbra, Inc.
    • Stryker Corporation
    • Medtronic plc
    • Boston Scientific Corporation
    • Terumo Corporation
    • Koninklijke Philips NV
    • Johnson & Johnson
    • Becton, Dickinson and Company
    • Abbott Laboratories
    • AngioDynamics, Inc.
Product Code: MRR-030298DFFFC6

The Thrombectomy Devices Market is projected to grow by USD 3.30 billion at a CAGR of 7.64% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.83 billion
Estimated Year [2025] USD 1.97 billion
Forecast Year [2032] USD 3.30 billion
CAGR (%) 7.64%

Thrombectomy devices have moved from niche interventions to essential tools across several acute vascular care pathways, driven by advances in device engineering, imaging integration, and accumulated clinical evidence. This introduction frames the contemporary landscape where clinicians, hospital systems, and specialty centers increasingly rely on rapid mechanical and combined approaches to remove occlusive thrombi in cerebral, venous, and pulmonary circulations. As device profiles evolve, the boundary between procedure types and technology modalities has become more fluid, prompting interdisciplinary collaboration among neurointerventionalists, vascular surgeons, and interventional radiologists.

Consequently, procurement and utilization decisions are no longer based solely on device cost or brand familiarity. Instead, clinical outcomes data, ease of use in hybrid operating environments, vendor support for training, and supply continuity are central determinants. In parallel, regulatory agencies have refined pathways for device clearance and post-market surveillance, placing greater emphasis on real-world performance metrics. Taken together, these dynamics underscore the need for stakeholders to reconcile clinical imperatives with operational resilience, as the sector adapts to heightened demand for rapid reperfusion therapies and standardized care pathways across diverse health systems.

How converging innovations in device design, imaging integration, and care pathway optimization are reshaping clinical adoption and institutional investments

The landscape for thrombectomy devices is undergoing transformative shifts driven by convergence of technological innovation, procedural standardization, and health system priorities that emphasize speed and outcomes. Miniaturization and material science advances have improved trackability and deliverability in complex vascular anatomy, while novel designs have expanded the therapeutic envelope for aspiration techniques and stent retriever platforms. Simultaneously, imaging modalities and intra-procedural guidance systems have matured, enabling more precise device placement and shorter procedure times, which together support better clinical outcomes and broaden appropriate use criteria.

Regulatory and reimbursement environments are also evolving, with payers increasingly recognizing the downstream cost benefits of timely mechanical reperfusion for stroke and selected pulmonary embolism cases. This shift incentivizes institutions to invest in targeted training, hybrid suite capabilities, and process optimization to maximize first-pass success. Moreover, the industry has seen accelerated collaboration between device manufacturers and clinical networks to generate robust real-world evidence and to speed adoption through structured training programs. As a result, adoption patterns now reflect a balance between innovation adoption curves and pragmatic considerations such as inventory management, staff competencies, and alignment with acute care pathways.

Assessing the multifaceted consequences of newly implemented tariffs on supply chains, procurement strategies, and total cost considerations across thrombectomy device stakeholders

The imposition of new United States tariffs in 2025 introduced a fresh layer of complexity to an already intricate global supply chain for thrombectomy devices. While tariffs aim to protect domestic manufacturing and strategic industries, they have also altered cost structures for companies that rely on cross-border production of specialized components and raw materials. Manufacturers with vertically integrated supply chains in key markets have been better positioned to absorb or mitigate tariff-related cost pressures, whereas firms dependent on single-source suppliers in affected jurisdictions have faced increased procurement volatility.

In response, many stakeholders accelerated active risk management measures including supplier diversification, onshoring of critical production stages, and renegotiation of long-term contracts to secure favorable terms. Distributors and hospital purchasing teams likewise intensified inventory planning to prevent short-term shortages during transitional tariff implementation periods. Importantly, procurement strategies shifted toward evaluating total cost of ownership rather than unit pricing alone, considering factors such as lead time predictability, warranty and service provision, and training support. Going forward, the cumulative impact of tariffs has elevated strategic supply chain resilience to a core competitive attribute for device manufacturers and for health systems seeking uninterrupted access to critical thrombectomy technologies.

Comprehensive segmentation analysis revealing how device class, procedural subtype, technological approach, distribution strategy, and care setting determine clinical and commercial priorities

A nuanced segmentation lens reveals how device choice, procedural indication, underlying technology, distribution approach, and end-user setting collectively shape market dynamics and clinical workflows. Based on device, the market divides into aspiration catheters and stent retrievers, each with distinct profiles for deliverability, clot engagement, and first-pass effect expectations; clinicians select between these device classes according to lesion morphology, vascular access complexity, and operator familiarity. Based on procedure, thrombectomy applications span deep vein thrombosis, ischemic stroke, and pulmonary embolism, with further clinical granularity where deep vein thrombosis is characterized by distal versus iliofemoral presentations, ischemic stroke is classified into anterior circulation versus posterior circulation occlusions, and pulmonary embolism is assessed as massive or submassive cases; these procedural subtypes drive specific device design priorities, adjunctive technologies, and requisite clinician skill sets.

Based on technology, laser assisted, mechanical, and pharmacomechanical approaches provide differentiated mechanisms for thrombus removal or modification, and the choice between them reflects trade-offs among efficacy, procedural duration, bleeding risk, and adjunctive anticoagulation needs. Based on distribution channel, manufacturers and suppliers balance direct sales relationships against online platforms that facilitate expedited procurement and broader geographic reach, influencing training models and post-sale service expectations. Based on end user, ambulatory surgical centers, hospitals, and specialty clinics each impose different operational constraints and purchasing behaviors, where ambulatory settings prioritize streamlined procedural throughput, hospitals emphasize comprehensive on-call coverage and hybrid suites, and specialty clinics focus on subspecialized expertise and case mix. Together, these segmentation dimensions determine product development roadmaps, clinical education investments, and commercialization strategies that align with the procedural mix and care delivery context.

Regional differentiation in clinical infrastructure, regulatory regimes, and adoption drivers shaping tailored commercialization and training approaches across global markets

Regional dynamics vary significantly, with each geography presenting unique clinical practice patterns, regulatory frameworks, and infrastructure maturity that influence device adoption and support models. In the Americas, well-established acute stroke networks, substantial hospital investment in hybrid interventional suites, and concentrated centers of excellence drive demand for high-performance thrombectomy platforms and integrated training programs. Reimbursement structures and emergency medical services protocols in several countries in the region also prioritize rapid triage and transfer pathways, which has a direct bearing on device selection and stocking philosophies at tertiary centers.

Europe, Middle East & Africa presents a heterogeneous landscape where advanced urban centers exhibit rapid uptake of novel thrombectomy technologies while rural and resource-constrained areas face access challenges. Regulatory harmonization efforts in some European jurisdictions streamline market entry for devices, but divergent procurement rules and national health system priorities necessitate differentiated commercialization strategies. In the Asia-Pacific region, rapid investment in stroke care infrastructure and increased procedural volumes in major markets have stimulated local manufacturing partnerships and regional distribution networks. However, variability in clinical training capacity and uneven availability of hybrid environments require tailored educational outreach and flexible service models to support sustained adoption across diverse hospital systems.

How manufacturers are combining iterative device innovation, evidence generation, and expanded service models to strengthen clinical adoption and competitive differentiation

Key companies in the thrombectomy device arena are navigating a landscape defined by rapid innovation, heightened clinical expectations, and supply chain recalibration. Industry leaders are prioritizing investments in product portfolios that enhance first-pass success, facilitate access in tortuous anatomy, and reduce procedural time. Many firms are pursuing iterative device improvements and modular systems that integrate with imaging platforms and offer seamless compatibility with ancillary tools. Strategic alliances between device innovators and imaging or navigation providers have become more commonplace as companies seek to create comprehensive procedural ecosystems that deliver measurable clinical advantages.

Competitive positioning is also influenced by approaches to clinical evidence generation and post-market surveillance. Companies that invest in robust multicenter registries, investigator-initiated trials, and clinician training programs tend to accelerate credibility among high-volume centers and referral networks. In parallel, smaller, more nimble entrants are focusing on niche innovations or cost-efficient manufacturing approaches to address specific procedural gaps or resource-constrained environments. Across the spectrum, manufacturers are enhancing service offerings including hands-on training, simulation curricula, and remote proctoring, recognizing that after-sales support and clinician confidence are pivotal to sustained device utilization.

Actionable strategies for manufacturers, clinicians, and health systems to align product innovation, training, and supply resilience with sustainable clinical and commercial outcomes

Industry leaders should prioritize a coordinated strategy that aligns product development with demonstrated clinical value, operational workflows, and supply chain resilience. First, design efforts must concentrate on improving procedural efficiency and versatility, ensuring devices perform reliably across the key procedural presentations clinicians encounter. Manufacturers and clinical leaders should co-develop training curricula and simulation-based proficiency programs to shorten the learning curve and support diffusion across hospitals and specialty centers. In parallel, investment in robust real-world evidence generation and registry participation will reinforce clinical trust and inform guideline incorporation.

Operationally, organizations must diversify sourcing and consider selective onshoring or dual-sourcing for critical components to mitigate tariff and geopolitical risks. Distribution strategies should blend direct engagement with high-volume centers and digital procurement channels for broader market reach, while maintaining strong after-sales service capabilities. Health systems and procurement teams should adopt total cost of ownership frameworks to evaluate vendor proposals, factoring in service, training, and inventory predictability. Finally, collaboration between manufacturers, payers, and clinical networks to demonstrate value-based outcomes will support sustainable access and appropriate reimbursement pathways, thereby aligning incentives across the care continuum.

Methodological overview detailing a triangulated approach of expert interviews, regulatory and clinical literature review, and cross-validated data synthesis to ensure robust insights

This analysis synthesizes insights derived from a triangulated research methodology that combines primary qualitative engagements with clinical and procurement experts, detailed review of regulatory filings and device labeling, and examination of peer-reviewed clinical literature and procedure registries. Primary research included structured interviews with interventionalists, vascular specialists, hospital supply managers, and industry executives to capture operational challenges, adoption barriers, and real-world device performance considerations. Secondary sources encompassed regulatory approval summaries, published clinical trials, conference proceedings, and white papers that document procedural outcomes, device-specific metrics, and practice guidelines.

Data integrity was assured through cross-validation across multiple information streams, reconciliation of divergent perspectives, and rigorous source attribution. Analytical techniques included thematic synthesis of interview data, technology readiness assessments, and supply chain risk mapping. Limitations of the methodology are acknowledged, including variable transparency in proprietary commercial agreements and the evolving nature of post-market surveillance data. To mitigate these constraints, the research incorporated sensitivity checks and sought corroboration from independent clinical experts to ensure balanced interpretation of trends and strategic implications.

Strategic synthesis emphasizing the interplay of innovation, evidence generation, and operational resilience as determinants of long-term success for thrombectomy stakeholders

In conclusion, thrombectomy devices occupy an increasingly central role across acute vascular care, propelled by device innovation, enhanced imaging integration, and the institutional imperative to deliver timely reperfusion. Stakeholders must adapt to a complex operating environment where procedural variability, regulatory nuance, and supply chain dynamics intersect. Strategic success will hinge upon aligning product capabilities with clinician needs, strengthening evidence generation, and ensuring operational resilience through diversified sourcing and sophisticated distribution strategies.

Looking ahead, organizations that marry technological excellence with comprehensive training and reliable post-sale support will be best positioned to capture long-term clinical trust and utilization. Equally important is the recognition that collaborative efforts among manufacturers, health systems, and payers to demonstrate meaningful patient outcomes will accelerate appropriate access and integration of thrombectomy therapies across broader care pathways. This synthesis should inform executive decision-making, guiding prioritization of investments that balance near-term operational imperatives with sustained clinical impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of dual-mechanism aspiration and stent retriever devices for comprehensive stroke care
  • 5.2. Increasing integration of AI-driven imaging and real-time analytics for optimized thrombectomy outcomes
  • 5.3. Growth in demand for catheter designs with enhanced navigability for distal vessel recanalization
  • 5.4. Expansion of portable and mobile interventional suites enabling rapid on-site stroke interventions
  • 5.5. Development of biodegradable and drug-eluting thrombectomy devices to reduce reocclusion rates
  • 5.6. Adoption of robotic catheter guidance systems to improve precision in complex intracranial procedures
  • 5.7. Strategic partnerships between device manufacturers and telestroke networks for remote procedure support

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Thrombectomy Devices Market, by Device

  • 8.1. Aspiration Catheters
  • 8.2. Stent Retrievers

9. Thrombectomy Devices Market, by Procedure

  • 9.1. Deep Vein Thrombosis
    • 9.1.1. Distal
    • 9.1.2. Iliofemoral
  • 9.2. Ischemic Stroke
    • 9.2.1. Anterior Circulation
    • 9.2.2. Posterior Circulation
  • 9.3. Pulmonary Embolism
    • 9.3.1. Massive
    • 9.3.2. Submassive

10. Thrombectomy Devices Market, by Technology

  • 10.1. Laser Assisted
  • 10.2. Mechanical
  • 10.3. Pharmacomechanical

11. Thrombectomy Devices Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Online Platforms

12. Thrombectomy Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals
  • 12.3. Specialty Clinics

13. Thrombectomy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Thrombectomy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Thrombectomy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Penumbra, Inc.
    • 16.3.2. Stryker Corporation
    • 16.3.3. Medtronic plc
    • 16.3.4. Boston Scientific Corporation
    • 16.3.5. Terumo Corporation
    • 16.3.6. Koninklijke Philips N.V.
    • 16.3.7. Johnson & Johnson
    • 16.3.8. Becton, Dickinson and Company
    • 16.3.9. Abbott Laboratories
    • 16.3.10. AngioDynamics, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. THROMBECTOMY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. THROMBECTOMY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. THROMBECTOMY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DISTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DISTAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DISTAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DISTAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DISTAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DISTAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ILIOFEMORAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ILIOFEMORAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ILIOFEMORAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ILIOFEMORAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ILIOFEMORAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ILIOFEMORAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ANTERIOR CIRCULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ANTERIOR CIRCULATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ANTERIOR CIRCULATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ANTERIOR CIRCULATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ANTERIOR CIRCULATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ANTERIOR CIRCULATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY POSTERIOR CIRCULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY POSTERIOR CIRCULATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY POSTERIOR CIRCULATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY POSTERIOR CIRCULATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY POSTERIOR CIRCULATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY POSTERIOR CIRCULATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY MASSIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY MASSIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY MASSIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY MASSIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY MASSIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY MASSIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SUBMASSIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SUBMASSIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SUBMASSIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SUBMASSIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SUBMASSIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SUBMASSIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY LASER ASSISTED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY LASER ASSISTED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY LASER ASSISTED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY LASER ASSISTED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY LASER ASSISTED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY LASER ASSISTED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PHARMACOMECHANICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PHARMACOMECHANICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PHARMACOMECHANICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PHARMACOMECHANICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PHARMACOMECHANICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY PHARMACOMECHANICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ONLINE PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ONLINE PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ONLINE PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY ONLINE PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 162. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 168. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 176. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 178. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 182. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 184. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 230. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 232. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 236. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 238. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 248. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 249. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 250. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 251. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 252. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 253. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 254. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 286. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 287. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 288. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 289. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 290. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 291. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 292. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 293. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 294. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 296. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 297. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 298. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 299. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 300. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 301. GCC THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. GCC THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. GCC THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 304. GCC THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 305. GCC THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 306. GCC THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 307. GCC THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 308. GCC THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 309. GCC THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2024 (USD MILLION)
  • TABLE 310. GCC THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2025-2032 (USD MILLION)
  • TABLE 311. GCC THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2024 (USD MILLION)
  • TABLE 312. GCC THROMBECTOMY DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2025-2032 (USD MILLION)
  • TABLE 313. GCC THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 314. GCC THROMBECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 315. GCC THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 316. GCC THROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 317. GCC THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 318. GCC THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE, 2025-2032 (USD MILLION)
  • TABLE 323. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 325. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2024 (USD MILLION)
  • TABLE 326. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2025-2032 (USD MILLION)
  • TABLE 327. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 201